Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Early Left Ventricular Dysfunction in Children after Hematopoietic Stem Cell Transplantation for Acute Leukemia: A Case Control Study Using Speckle Tracking Echocardiography

  • Yoon, Ji-Hong (Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Hye Jin (Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Eun-Jung (Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Moon, Sena (Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jae Young (Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jae Wook (Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Chung, Nack Gyun (Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Cho, Bin (Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Hack Ki (Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2014.09.26
  • Accepted : 2014.10.17
  • Published : 2015.01.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: Cardiovascular complications are the leading cause of morbidity and mortality in childhood cancer survivors. Hematopoietic stem cell transplantation (HSCT) is a curable therapy for pediatric cancer. However, changes in cardiac function in children after HSCT are not well known. We assessed left ventricular (LV) function in children after HSCT using speckle tracking echocardiography (STE). Subjects and Methods: Forty consecutive patients with median age of 11.9 years (range, 1.5-16 years) who received HSCT for acute leukemia and had comprehensive echocardiography before and after (median 9.2 month) HSCT were included in this study. The LV function parameters including conventional tissue Doppler imaging (TDI) and STE data were collected from pre- and post-HSCT echocardiography. These data were compared to those of 39 age-matched normal controls. Results: Compared to normal controls, post HSCT patients had similar (p=0.06) LV ejection fraction. However, the following three LV function parameters were significantly decreased in post HSCT patients: rate-corrected velocity of circumferential fiber shortening (p=0.04), mitral inflow E velocity (p<0.001), and mitral septal annular E' velocity (p=0.03). The following four STE parameters were also significantly decreased in post HSCT patients: LV global circumferential systolic strain (p<0.01), strain rate (SR, p=0.01), circumferential diastolic SR (p<0.01), and longitudinal diastolic SR (p<0.001). There was no significant change in TDI or STE parameters after HSCT compared to pre-HSCT. Patients with anthracycline cumulative dose >400 mg/m2 showed significantly (p<0.05) lower circumferential systolic strain and circumferential diastolic SR. Conclusion: Subclinical cardiac dysfunction is evident in children after HSCT. It might be associated with pre-HSCT anthracycline exposure with little effect of conditioning regimens. Serial monitoring of cardiac function is mandatory for all children following HSCT.

Keywords

References

  1. Ballen KK, King RJ, Chitphakdithai P, et al. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008;14(9 Suppl):2-7.
  2. Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 2012;120:1165-74. https://doi.org/10.1182/blood-2012-05-378943
  3. Reulen RC, Winter DL, Frobisher C, et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA 2010;304:172-9. https://doi.org/10.1001/jama.2010.923
  4. Mertens AC. Cause of mortality in 5-year survivors of childhood cancer. Pediatr Blood Cancer 2007;48:723-6. https://doi.org/10.1002/pbc.21114
  5. Nieder ML, McDonald GB, Kida A, et al. National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: longterm organ damage and dysfunction. Biol Blood Marrow Transplant 2011;17:1573-84. https://doi.org/10.1016/j.bbmt.2011.09.013
  6. Cardous-Ubbink MC, Heinen RC, Langeveld NE, et al. Long-term causespecific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer 2004;42:563-73. https://doi.org/10.1002/pbc.20028
  7. MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Abanto ZU, McBride ML. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada. Pediatr Blood Cancer 2007;48:460-7. https://doi.org/10.1002/pbc.20922
  8. Kremer LC, van Dalen EC, Offringa M, Voûte PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol 2002;13:503-12. https://doi.org/10.1093/annonc/mdf118
  9. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 2003;97:2869-79. https://doi.org/10.1002/cncr.11407
  10. Lähteenmäki PM, Chakrabarti S, Cornish JM, Oakhill AH. Outcome of single fraction total body irradiation-conditioned stem cell transplantation in younger children with malignant disease--comparison with a busulphan-cyclophosphamide regimen. Acta Oncol 2004;43:196-203. https://doi.org/10.1080/02841860310023471
  11. Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 2001;28:283-7. https://doi.org/10.1038/sj.bmt.1703133
  12. Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 1991;9:1215-23. https://doi.org/10.1200/JCO.1991.9.7.1215
  13. Armenian SH, Sun CL, Kawashima T, et al. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 2011;118:1413-20. https://doi.org/10.1182/blood-2011-01-331835
  14. Armenian SH, Sun CL, Mills G, et al. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010;16:1138-44. https://doi.org/10.1016/j.bbmt.2010.02.021
  15. Daly KP, Colan SD, Blume ED, et al. Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT. Bone Marrow Transplant 2011;46:1532-9. https://doi.org/10.1038/bmt.2010.345
  16. Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers. Version 4.0. Arcadia, CA: Children's Oncology Group; 2013. Available from: www. survivorshipguidelines.org.
  17. Lipshultz SE, Easley KA, Orav EJ, et al. Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study. Circulation 2001;104:310-6. https://doi.org/10.1161/01.CIR.104.3.310
  18. Cheung YF, Hong WJ, Chan GC, Wong SJ, Ha SY. Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy. Heart 2010;96:1137-41. https://doi.org/10.1136/hrt.2010.194118
  19. Alehan D, Sahin M, Varan A, Yildirim I, Kupeli S, Buyukpamukcu M. Tissue Doppler evaluation of systolic and diastolic cardiac functions in long-term survivors of Hodgkin lymphoma. Pediatr Blood Cancer 2012; 58:250-5. https://doi.org/10.1002/pbc.23281
  20. Baysal T, Koksal Y, Oran B, Sen M, Unal E, Cimen D. Cardiac functions evaluated with tissue Doppler imaging in childhood cancers treated with anthracyclines. Pediatr Hematol Oncol 2010;27:13-23. https://doi.org/10.3109/08880010903352299
  21. Rathe M, Carlsen NL, Oxhoj H. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;48:663-7. https://doi.org/10.1002/pbc.20313
  22. Shankar SM, Marina N, Hudson MM, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics 2008;121:e387-96. https://doi.org/10.1542/peds.2007-0575
  23. Chow PC, Liang XC, Cheung EW, Lam WW, Cheung YF. New two-dimensional global longitudinal strain and strain rate imaging for assessment of systemic right ventricular function. Heart 2008;94:855-9. https://doi.org/10.1136/hrt.2007.131862
  24. Mavinkurve-Groothuis AM, Weijers G, Groot-Loonen J, et al. Interobserver, intraobserver and intrapatient reliability scores of myocardial strain imaging with 2-d echocardiography in patients treated with anthracyclines. Ultrasound Med Biol 2009;35:697-704. https://doi.org/10.1016/j.ultrasmedbio.2008.09.026
  25. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-82. https://doi.org/10.1056/NEJMsa060185
  26. Bu’Lock FA, Mott MG, Oakhill A, Martin RP. Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology. Br Heart J 1995; 73:340-50. https://doi.org/10.1136/hrt.73.4.340
  27. van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer 2006;42:3191-8. https://doi.org/10.1016/j.ejca.2006.08.005
  28. Chow EJ, Mueller BA, Baker KS, et al. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med 2011;155:21-32. https://doi.org/10.7326/0003-4819-155-1-201107050-00004
  29. Biswas M, Sudhakar S, Nanda NC, et al. Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions. Echocardiography 2013;30:88-105. https://doi.org/10.1111/echo.12079

Cited by

  1. Changes in Bi-ventricular Function After Hematopoietic Stem Cell Transplant as Assessed by Speckle Tracking Echocardiography vol.39, pp.2, 2018, https://doi.org/10.1007/s00246-017-1764-9
  2. Use of speckle tracking in the evaluation of late subclinical myocardial damage in survivors of childhood acute leukaemia vol.34, pp.9, 2015, https://doi.org/10.1007/s10554-018-1346-9
  3. Pretransplant Cardiac Evaluation Using Novel Technology vol.8, pp.5, 2015, https://doi.org/10.3390/jcm8050690